{"id":547,"date":"2020-07-18T11:27:50","date_gmt":"2020-07-18T11:27:50","guid":{"rendered":"https:\/\/knight-pharma.com\/web\/?page_id=547"},"modified":"2024-06-15T00:17:53","modified_gmt":"2024-06-15T00:17:53","slug":"metofur","status":"publish","type":"page","link":"https:\/\/knight-pharma.com\/web\/metofur\/","title":{"rendered":"METOFUR"},"content":{"rendered":"\n<p><mark style=\"background-color:rgba(0, 0, 0, 0);color:#0071a1\" class=\"has-inline-color\"><strong>Powder for Oral Use<\/strong><\/mark><\/p>\n\n\n\n<p><a href=\"https:\/\/knight-pharma.com\/web\/mastitube\/\">&lt;&lt;PREVIOUS |<\/a><a href=\"https:\/\/knight-pharma.com\/web\/metroject-50\/\">| NEXT&gt;&gt;<\/a><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2022\/05\/Metofur.jpg\" alt=\"\" class=\"wp-image-1864\" srcset=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2022\/05\/Metofur.jpg 500w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2022\/05\/Metofur-300x300.jpg 300w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2022\/05\/Metofur-150x150.jpg 150w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2022\/05\/Metofur-200x200.jpg 200w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/figure>\n<\/div>\n\n\n<p><strong><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">COMPOSITION : <\/span><\/strong><\/p>\n\n\n\n<p>1 g of the drug contains active substances (mg): <\/p>\n\n\n\n<p>Metronidazole \u2013 110<\/p>\n\n\n\n<p>Oxytetracycline hydrochloride 25<\/p>\n\n\n\n<p>Furazolidon 65<\/p>\n\n\n\n<p>Excipients: up to 1 g.<\/p>\n\n\n\n<p><strong><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">DESCRIPTION<\/span><\/strong><span style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\">: <\/span><\/p>\n\n\n\n<p>Powder with a light yellow to yellow-brown color, odorless.<\/p>\n\n\n\n<p><strong><span class=\"has-inline-color has-vivid-red-color\">PHARMACOLOGICAL CHARACTERISTICS:<\/span> <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Metronidazole:<\/strong>&nbsp;Belongs to the 5-nitroimidazole group. It functions by reducing the 5-nitroimidazole group through intracellular transport proteins of anaerobic bacteria and protozoa, which then interacts with the DNA of microbial cells to inhibit nucleic acid synthesis, leading to microorganism death. Effective against protozoa (e.g., Trichomonas vaginalis, Giardia intestinalis) and obligate anaerobic bacteria (e.g., Bacteroides spp.), as well as some gram-positive bacteria (e.g., Clostridium spp.).<\/li>\n\n\n\n<li><strong>Oxytetracycline Hydrochloride:<\/strong>&nbsp;A bacteriostatic antibiotic that disrupts protein synthesis during its interaction with ribosomes and reduces the permeability of the cytoplasmic membrane of susceptible microorganisms. It has a broad spectrum of activity against gram-positive and gram-negative microorganisms including Streptococcus spp., E. coli, and Salmonella spp.<\/li>\n\n\n\n<li><strong>Furazolidone:<\/strong>&nbsp;A synthetic antibacterial and antiprotozoal drug, a derivative of nitrofuran. It blocks the enzyme system of bacteria sensitive to it and is active against Giardia, Trichomonas, Coccidia, E. Coli, and Salmonella spp.<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image is-style-rounded\">\n<figure class=\"alignright size-full is-resized\"><img decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2024\/06\/Metofur-20-1.png\" alt=\"\" class=\"wp-image-5234\" style=\"width:364px;height:auto\" srcset=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2024\/06\/Metofur-20-1.png 500w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2024\/06\/Metofur-20-1-300x300.png 300w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2024\/06\/Metofur-20-1-150x150.png 150w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2024\/06\/Metofur-20-1-200x200.png 200w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/figure>\n<\/div>\n\n\n<p><strong><span class=\"has-inline-color has-vivid-red-color\">APPLICATION:<\/span><\/strong> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dogs, Cats:<\/strong>&nbsp;Treatment of gastrointestinal diseases and prevention of surgical complications caused by microorganisms sensitive to the components of the drug.<\/li>\n\n\n\n<li><strong>Fur Animals (Minks, Foxes):<\/strong>&nbsp;Prevention and treatment of coccidiosis and gastrointestinal diseases caused by pathogens susceptible to the drug components.<\/li>\n\n\n\n<li><strong>Fancy Pigeons:<\/strong>&nbsp;Prevention and treatment of blackhead, coccidiosis, salmonellosis, and trichomoniasis caused by sensitive microorganisms.<\/li>\n<\/ul>\n\n\n\n<p><strong><span class=\"has-inline-color has-vivid-red-color\">DOSAGE:<\/span> <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dogs, Cats:<\/strong>&nbsp;0.1-0.2 g per 1 kg body weight, 3 times a day for 7-10 days.<\/li>\n\n\n\n<li><strong>Fur Animals (Minks, Foxes):<\/strong>&nbsp;0.2-0.3 g per 1 kg body weight, 3 times a day for 3-5 days.<\/li>\n\n\n\n<li><strong>Calves:<\/strong>&nbsp;Prophylactic dose during weaning is 1.0-1.5 grams for every 10 animals for 2 weeks.<\/li>\n\n\n\n<li><strong>Fancy Pigeons:<\/strong>&nbsp;Therapeutic dose is 3 g per 1 kg of feed daily for 7-10 days; prophylactic dose is 1 g per 1 kg of feed daily for 2 weeks.<\/li>\n<\/ul>\n\n\n\n<p><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\"><strong>CONTRAINDICATIONS<\/strong>:<\/mark> <\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Hypersensitivity to any components of the drug.<\/li>\n\n\n\n<li>Do not use in food-producing animals.<\/li>\n<\/ul>\n\n\n\n<p><strong><span class=\"has-inline-color has-vivid-red-color\">PRECAUTIONS:<\/span> <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Repeat treatment after a 10-day break.<\/li>\n\n\n\n<li>Use with caution in animals with impaired renal and liver function.<\/li>\n<\/ul>\n\n\n\n<p><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-red-color\"><strong>PACKAGING:<\/strong> <\/mark><\/p>\n\n\n\n<p>Packages 20, 100 g.<\/p>\n\n\n\n<p><strong><span class=\"has-inline-color has-vivid-red-color\">STORAGE:<\/span> <\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Store in a dry, dark place, out of reach of children, at a temperature between 2\u00b0C and 20\u00b0C.<\/li>\n\n\n\n<li>Store separately from food, drinks, and animal feed.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-accent-2-color has-text-color has-link-color wp-elements-b9153a09123a42b41b072c840d7c97aa\"><strong>FOR VETERINARY USE ONLY!<\/strong><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Powder for Oral Use &lt;&lt;PREVIOUS || NEXT&gt;&gt; COMPOSITION : 1 g of the drug contains active substances (mg): Metronidazole \u2013 110 Oxytetracycline hydrochloride 25 Furazolidon 65 Excipients: up to 1 g. DESCRIPTION: Powder with a light yellow to yellow-brown color, odorless. PHARMACOLOGICAL CHARACTERISTICS: APPLICATION: DOSAGE: CONTRAINDICATIONS: PRECAUTIONS: PACKAGING: Packages 20, &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-547","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/547","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/comments?post=547"}],"version-history":[{"count":15,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/547\/revisions"}],"predecessor-version":[{"id":5237,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/547\/revisions\/5237"}],"wp:attachment":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/media?parent=547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}